These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

410 related items for PubMed ID: 12587252

  • 1. Toxicokinetics and physiologically based toxicokinetics in toxicology and risk assessment.
    Dixit R, Riviere J, Krishnan K, Andersen ME.
    J Toxicol Environ Health B Crit Rev; 2003; 6(1):1-40. PubMed ID: 12587252
    [Abstract] [Full Text] [Related]

  • 2. Development of physiologically based pharmacokinetic and physiologically based pharmacodynamic models for applications in toxicology and risk assessment.
    Andersen ME.
    Toxicol Lett; 1995 Sep; 79(1-3):35-44. PubMed ID: 7570672
    [Abstract] [Full Text] [Related]

  • 3. Toxicokinetics: an analytical tool for assessing chemical hazards to man.
    Clewell HJ, Andersen ME, MacNaughton MG, Stuart BO.
    Aviat Space Environ Med; 1988 Nov; 59(11 Pt 2):A125-31. PubMed ID: 3202802
    [Abstract] [Full Text] [Related]

  • 4. [Significance of ICH--toxicokinetics guidance and its practice--a useful approach for safety drug development].
    Tsuda M, Ohno Y.
    Kokuritsu Iyakuhin Shokuhin Eisei Kenkyusho Hokoku; 1997 Nov; (115):1-14. PubMed ID: 9641814
    [Abstract] [Full Text] [Related]

  • 5. Interspecies scaling and comparisons in drug development and toxicokinetics.
    Ings RM.
    Xenobiotica; 1990 Nov; 20(11):1201-31. PubMed ID: 2275215
    [Abstract] [Full Text] [Related]

  • 6. PBPK models in risk assessment--A focus on chloroprene.
    DeWoskin RS.
    Chem Biol Interact; 2007 Mar 20; 166(1-3):352-9. PubMed ID: 17324392
    [Abstract] [Full Text] [Related]

  • 7. Investigation of the potential impact of benchmark dose and pharmacokinetic modeling in noncancer risk assessment.
    Clewell HJ, Gentry PR, Gearhart JM.
    J Toxicol Environ Health; 1997 Dec 26; 52(6):475-515. PubMed ID: 9397182
    [Abstract] [Full Text] [Related]

  • 8. Computational toxicology as implemented by the U.S. EPA: providing high throughput decision support tools for screening and assessing chemical exposure, hazard and risk.
    Kavlock R, Dix D.
    J Toxicol Environ Health B Crit Rev; 2010 Feb 26; 13(2-4):197-217. PubMed ID: 20574897
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Proper knowledge on toxicokinetics improves human hazard testing and subsequent health risk characterisation. A case study approach.
    Bessems JG, Geraets L.
    Regul Toxicol Pharmacol; 2013 Dec 26; 67(3):325-34. PubMed ID: 24051162
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Metabolism, variability and risk assessment.
    Dorne JL.
    Toxicology; 2010 Feb 09; 268(3):156-64. PubMed ID: 19932147
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Toxicokinetics in the National Toxicology Program.
    Goehl TJ.
    NIDA Res Monogr; 1997 Feb 09; 173():273-304. PubMed ID: 9260193
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 21.